article thumbnail

Chasing that ‘Time magazine cover potential’

PharmaVoice

Rami Elghandour was already retired. Then CAR-T specialist Arcellx lured him back into the industry to try to change the world.

246
246
article thumbnail

Germany considers banning the export of Novo Nordisk's Ozempic

Fierce Pharma

The craze is such that Germany’s drug regulator is considering banning the export of Ozempic, according to a report in Der Spiegel magazine. | How popular have Novo Nordisk’s semaglutide drugs become for weight loss in Europe?

298
298
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec

Fierce Pharma

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.

FDA 211
article thumbnail

Magazine-How delays derailed Covid-19 vaccination in Africa

Pharmaceutical Technology

The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

Pharma 110
article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

The post Magazine: CRISPR gene therapies cut through in 2023 appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

article thumbnail

Magazine: What Rishi Sunak can do for the UK pharma industry

Pharmaceutical Technology

The post Magazine: What Rishi Sunak can do for the UK pharma industry appeared first on Pharmaceutical Technology. All this, and the latest pharma industry news , comment, data, and analysis from GlobalData. Click here to view the latest issue of Pharmaceutical Technology Focus.

Pharma 93
article thumbnail

Magazine: Left in limbo: when pharma halts rare disease research

Pharmaceutical Technology

Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.

Pharma 98